Infectious Disease Clinics of North America volume 19, issue 1, P151-168 2005 DOI: 10.1016/j.idc.2004.11.004 View full text
Anthony A. Marfin, Rachel S. Barwick Eidex, Phyllis E. Kozarsky, Martin S. Cetron

Abstract: Appropriate administration of yellow fever or Japanese encephalitis vaccines to travelers requires an assessment of the traveler's risk for infection with these vector-borne flaviviruses during their travels and the presence of risk factors for adverse events following immunization. Japanese encephalitis and yellow fever vaccines have been more frequently associated with serious adverse events following immunization since the early 1980s and the late 1990s, respectively. This article describes the adverse even…

expand abstract